These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36563023)

  • 21. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
    Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
    Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
    Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
    Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer.
    Tsai YS; Jou YC; Tung CL; Lin CT; Shen CH; Chen SY; Tsai HT; Lai CL; Wu CL; Tzai TS
    Virchows Arch; 2014 Jun; 464(6):717-24. PubMed ID: 24733561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
    Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
    Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
    Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
    Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C
    Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.
    Tsiatas M; Kalogeras KT; Manousou K; Wirtz RM; Gogas H; Veltrup E; Zagouri F; Lazaridis G; Koutras A; Christodoulou C; Pentheroudakis G; Petraki C; Bafaloukos D; Pectasides D; Kosmidis P; Samantas E; Karanikiotis C; Papakostas P; Dimopoulos MA; Fountzilas G
    Cancer Med; 2018 Oct; 7(10):5066-5082. PubMed ID: 30240146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.
    Wongpattaraworakul W; Choi A; Buchakjian MR; Lanzel EA; Kd AR; Simons AL
    BMC Cancer; 2024 Jun; 24(1):766. PubMed ID: 38926643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer.
    Chen R; Gong Y; Zou D; Wang L; Yuan L; Zhou Q
    PeerJ; 2019; 7():e7804. PubMed ID: 31616592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
    Koletsa T; Kotoula V; Koliou GA; Manousou K; Chrisafi S; Zagouri F; Sotiropoulou M; Pentheroudakis G; Papoudou-Bai A; Christodoulou C; Xepapadakis G; Zografos G; Petraki K; Pazarli E; Koutras A; Kourea HP; Bafaloukos D; Chatzopoulos K; Iliadis A; Markopoulos C; Venizelos V; Arnogiannaki N; Kalogeras KT; Kostopoulos I; Gogas H; Fountzilas G
    Cancer Immunol Immunother; 2020 Aug; 69(8):1549-1564. PubMed ID: 32303794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
    Liu L; Long M; Su S; Wang L; Liu J
    PeerJ; 2024; 12():e16747. PubMed ID: 38223758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Significance of Tumor-infiltrating Lymphocytes on Survival Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
    Tan HNC; Catedral LIG; San Juan MD
    J Immunother; 2021 Jan; 44(1):29-40. PubMed ID: 32909965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
    de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
    Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.
    Yao W; He JC; Yang Y; Wang JM; Qian YW; Yang T; Ji L
    Sci Rep; 2017 Aug; 7(1):7525. PubMed ID: 28790445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer.
    Liu K; Zhao K; Wang L; Sun E
    Pathol Res Pract; 2018 Aug; 214(8):1074-1080. PubMed ID: 29803657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients.
    Zhang D; Tang D; Heng Y; Zhu XK; Zhou L; Tao L; Lu LM
    Laryngoscope; 2021 Apr; 131(4):E1249-E1255. PubMed ID: 33107987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.
    Wang T; Zhang D; Tang D; Heng Y; Lu LM; Tao L
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5627-5636. PubMed ID: 36520215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Kawada T; Yanagisawa T; Rajwa P; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Pallauf M; König F; Pradere B; Araki M; Nasu Y; Shariat SF
    Clin Genitourin Cancer; 2024 Apr; 22(2):535-543.e4. PubMed ID: 38336572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.